Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 292 of 6351
-
New drug cocktail aims to replace chemo for lymphoma patients
Disease control Not yet recruitingThis is a single-center, phase 2, open-label clinical trial of a novel combination of polatuzumab vedotin, glofitamab, and tafasitamab (TPG) as first-line treatment of patients with diffuse large B cell lymphoma (DLBCL) or high-grade B cell lymphoma (HGBL).
Phase 2 • Sponsor: Brown University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could cord blood transfusions protect fragile preemies?
Disease control Not yet recruitingLong-term morbidities among very low birth weight infants remain a significant challenge. Oxidative stress is a key factor in the pathogenesis of 'free radical (FR) diseases of prematurity,' including retinopathy of prematurity, bronchopulmonary dysplasia, necrotizing enterocolit…
Sponsor: University of Parma • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could adding chemo to tarlatamab overcome resistance in lung cancer?
Disease control Not yet recruitingThe integration of tarlatamab, a bispecific T-cell engager molecule targeting both DLL3 and CD3, into the treatment algorithm for SCLC will substantially improve the prognosis of patients. Nevertheless, disease progression will inevitably occur. Major challenges for further impr…
Phase 2 • Sponsor: University of Cologne • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New care model aims to close cancer treatment gaps for people with mental illness
Disease control Not yet recruitingThe proposed project is an implementation-effectiveness randomized trial of a person-centered collaborative care model for patients with serious mental illness and new cancer. The BRIDGE NET intervention is theoretically informed, pragmatic, and delivered virtually by an interdis…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
A smartphone camera may help emergency doctors spot severe breathing trouble — a trial puts it to the test
Disease control Not yet recruitingDyspnea is the subjective sensation of difficult or uncomfortable breathing. It accounts for approximately 10% of emergency department visits and 8% of calls to Emergency Medical Communication Centers. Nearly half of patients presenting with dyspnea require hospital admission, 15…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Oral pills may help keep weight off after stopping popular injections
Disease control Not yet recruitingThis study will compare the effect of orforglipron and phentermine on weight maintenance.
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether it is feasible to conduct a larger study comparing transdermal menopausal hormone therapy (MHT) versus no hormone therapy in menopausal women with vasomotor symptoms (hot flashes and night sweats) and at least one cardiovascular…
Phase 4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a new device fix leaky heart valves that are hard to treat?
Disease control Not yet recruitingA pilot study to evaluate the safety and performance of the MRace System to treat severe mitral regurgitation and to gather data on its performance thereby providing guidance for future clinical development. The study is a single-arm registry with the last follow-up visit at 5 ye…
Sponsor: Polares Medical SA • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a daily pill keep a rare heart disease in check for the long haul?
Disease control Not yet recruitingThe AG10-504 study is an open-label extension study of acoramidis in participants with newly diagnosed transthyretin amyloid cardiomyopathy (ATTR-CM) or both ATTR-CM and transthyretin amyloid polyneuropathy (ATTR-PN).
Phase 3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
One injection vs. two: a new approach to shoulder surgery pain?
Symptom relief Not yet recruitingThis prospective, randomized, patient- and assessor-blinded, single-center non-inferiority trial will compare the analgesic efficacy of the Shoulder Posterior Pericapsular Nerve Group (SPENG) block with combined posterior suprascapular and axillary nerve blocks in adults undergoi…
Sponsor: Izmir City Hospital • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
One injection or many? a test to ease breast surgery pain
Symptom relief Not yet recruitingThis randomized clinical trial aims to evaluate and compare the analgesic efficacy of single Intertransverse Process Block (ITP) and multiple Intertransverse Process Block (ITP) in patients undergoing Breast Cancer Surgery. The primary outcome is Visual Analog Scale (VAS) during …
Sponsor: Antalya City Hospital • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Electric headset may help children with dyslexia read better
Disease control Recruiting nowThis study investigates whether transcranial electrical stimulation (tES) delivered during structured reading instruction affects reading proficiency in children with developmental dyslexia and related reading disabilities. Children aged 7 to 17 who have been identified as havin…
Sponsor: General Neuro Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
AI lifestyle coach may shield aging brains
Prevention Not yet recruitingThe goal of this clinical study is to learn if an artificial intelligence (AI)-assisted lifestyle intervention program can help protect memory and thinking skills in adults aged 40 years and older who do not have severe cognitive impairment. It will also learn whether the program…
Sponsor: National Research Center for Rehabilitation Technical Aids • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
One-Day brain zaps plus antibiotic could rewire PTSD in first responders
Disease control Not yet recruitingThe aim of this study is to examine the feasibility and tolerability of a one-day protocol of repetitive transcranial magnetic stimulation with D-cycloserine (DCS) as an augmentation strategy in first responders who have PTSD.
Phase 2 • Sponsor: Fidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can an 8-session program heal trauma and prevent partner violence in refugee couples?
Prevention Not yet recruitingForcibly displaced women and their male partners experience compounding social and structural vulnerabilities to intimate partner violence (IPV) and mental health challenges, yet rigorous studies or examples of evidence-based interventions that seek to prevent and reduce IPV and …
Sponsor: George Mason University • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Could Self-Swabs make anal cancer screening easier for people with HIV?
Knowledge-focused Not yet recruitingThis trial aims to evaluate if self-collected anal swabs (SCS) can be used for anal cancer screening. Currently, only clinician-collected anal swabs (CSC) are recommended for anal cancer screening, and this may be a barrier for people to access screening. About 700 people living …
Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Can a higher magnesium dose tame severe asthma attacks?
Disease control Not yet recruitingThe goal of this clinical is to compare treatment outcomes between high dose continuous IV Magnesium and standard therapy in the management of acute exacerbation of asthma in the emergency department. Participants will random assign to either high dose continuous IV drip or stand…
Sponsor: Thammasat University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
A new ultrasound measure may spot At-Risk babies in High-Blood-Pressure pregnancies
Diagnosis Not yet recruitingThe primary aim of this study is to evaluate the predictive value of the Amniotic-Umbilical-to-Cerebral Ratio (AUCR) in predicting composite adverse perinatal outcomes in women with hypertensive disorders of pregnancy and to compare its predictive performance with the traditional…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
A steroid premedication may tame the immune reaction to a melanoma therapy
Prevention Not yet recruitingThe goal of this clinical trial is to learn if a low dose of dexamethasone can prevent cytokine release syndrome in participants treated with tebentafusp for advanced uveal melanoma. The main questions the study aims to answer are: How many participants get cytokine release synd…
Phase 2 • Sponsor: University of California, San Diego • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Can a radioactive tracer help surgeons find hidden prostate cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether radioguided surgery can help surgeons find and remove lymph nodes containing prostate cancer in men whose cancer has returned in a small number of lymph nodes after previous prostate cancer treatment. It will also learn about th…
Phase 2 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC